Semax (30mg)
Semax is a synthetic heptapeptide originally derived from a fragment of adrenocorticotropic hormone (ACTH 4-10).
It is studied for its involvement in neurochemical signaling, cognitive-function pathways, stress-response models, and peptide-mediated gene regulation.
GENIQ supplies Semax exclusively for laboratory research use—not for human or animal administration.
$169.99
-
Official retailer
-
Quality guaranteed
-
Free delivery from $99
-
Free returns is available
What Is Semax?
Semax is a synthetic heptapeptide originally derived from a fragment of adrenocorticotropic hormone (ACTH 4-10).
It is studied for its involvement in neurochemical signaling, cognitive-function pathways, stress-response models, and peptide-mediated gene regulation.
GENIQ supplies Semax exclusively for laboratory research use—not for human or animal administration.
Peptide Overview
Semax is widely examined in neuroscience and molecular-biology research due to its selective activity on neurotrophic and neurotransmitter-related pathways.
In controlled laboratory models, researchers typically explore how Semax may promote changes in:
| Neurotransmitter-related biochemical systems |
| Brain-derived neurotrophic factor (BDNF) signaling pathways |
| Memory, attention, and learning-associated molecular markers |
| Stress-response and adaptation mechanisms |
| Gene-expression modulation in neuronal tissue |
| Oxidative-stress resilience and cellular-protection pathways |
| ACTH-derived peptide receptor interactions |
All findings remain limited to preclinical and in-vitro experimental environments.
History of Semax
Semax was developed by Russian research institutes in the late 1980s and early 1990s during investigations into ACTH-related peptide fragments.
Scientists focused on creating a stable, non-hormonal analog capable of influencing neurochemical and cognitive-associated pathways without affecting corticosteroid levels.
Semax has since been studied in:
| Behavioral neuroscience models |
| Memory and attention-related biochemical pathways |
| Stress-resilience research |
| Gene transcription and neurotrophic-factor studies |
| Neuroprotective molecular signaling investigations |
| Its origin from ACTH research positioned it as a notable compound in neurobiological studies. |
Peptide Structure
Sequence: Met-Glu-His-Phe-Pro-Gly-Pro
Certificates of Analysis
Semax — 30mg
Research Findings
Research involving Semax often focuses on:
| Neurotrophic pathways: Studies explore changes in BDNF expression and related molecular markers. |
| Cognitive-function models: Researchers examine biochemical patterns associated with memory, learning, and attention. |
| Stress-response regulation: Semax is evaluated for its interactions with signaling pathways involved in stress adaptation. |
| Neurotransmitter modulation: Investigations look at how Semax influences monoamine-linked biochemical activity. |
| Gene-expression behavior: Research observes transcriptional shifts related to neuronal plasticity and cellular protection. |
| Oxidative balance: Semax is included in studies involving antioxidant defenses and molecular resilience. |
These findings reflect laboratory experiments only and do not indicate clinical outcomes.
References
2. Neurogenesis Research Institute. “Semax influence on neurotrophic regulation and gene expression.”
3. Behavioral Pharmacology Unit. “Cognitive and molecular modeling of heptapeptide compounds.”
4. Stress & Adaptation Laboratory. “Peptide involvement in stress-response signaling pathways.”
FAQ
What type of research is Semax used for?
Semax is commonly used in studies involving neurochemical signaling, cognitive-function models, neurotrophic pathways, and stress-related molecular responses.
Does GENIQ provide Certificates of Analysis?
Yes. All GENIQ research materials include a COA verifying identity and purity.
Is Semax approved for human or veterinary use?
No. Semax is not FDA-approved and is not intended for human or animal administration.
Does GENIQ offer dosing or reconstitution instructions?
No. GENIQ does not provide any application, usage, or dosing guidance.
Who should handle this compound?
Only trained researchers within compliant laboratory facilities.
Research Use Only
All GENIQ compounds are intended strictly for laboratory research.
Not for human or animal consumption, medical use, or therapeutic application.
Nothing in this document should be interpreted as medical advice or as approval for use outside controlled scientific environments.
Semax is a synthetic heptapeptide originally derived from a fragment of adrenocorticotropic hormone (ACTH 4-10).
It is studied for its involvement in neurochemical signaling, cognitive-function pathways, stress-response models, and peptide-mediated gene regulation.
GENIQ supplies Semax exclusively for laboratory research use—not for human or animal administration.
